R462Q Mutation in Prostate Cancer Specimens


avatar Axel Muendlein 1 , * , avatar Alois H. Lang 2

Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
Department of Internal Medicine, Academic Teaching Hospital Feldkirch, Feldkirch, Austria

how to cite: Muendlein A, H. Lang A. R462Q Mutation in Prostate Cancer Specimens. Gene Cell Tissue. 2014;1(3):e23730. https://doi.org/10.17795/gct-23730.


  • 1.

    Seidabadi A, Rezatofighi SE, Motamedi H, Rashidi I. R462Q Mutation in Prostate Cancer Specimens. Gene Cell Tissue. 2014;1(2). ee19169.

  • 2.

    Pourmand GR, Allameh F, Mohammad K, Dehghani S, Pourmand B, Mehrsai AR, et al. Prostate cancer predicting factors: a preliminary report from Tehran. Urol J. 2012;9(4):667-72. [PubMed ID: 23235971].

  • 3.

    Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci. 2006;11:1388-413. [PubMed ID: 16368524].

  • 4.

    Silverman RH. Implications for RNase L in prostate cancer biology. Biochemistry. 2003;42(7):1805-12. [PubMed ID: 12590567]. https://doi.org/10.1021/bi027147i.

  • 5.

    Wei B, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, et al. RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis. Mol Biol Rep. 2012;39(3):2347-53. [PubMed ID: 21656378]. https://doi.org/10.1007/s11033-011-0985-x.

  • 6.

    Kheirandish P, Chinegwundoh F. Ethnic differences in prostate cancer. Br J Cancer. 2011;105(4):481-5. [PubMed ID: 21829203]. https://doi.org/10.1038/bjc.2011.273.

  • 7.

    Mi Y, Yu Q, Min Z, Xu B, Zhang L, Zhang W, et al. Arg462Gln and Asp541Glu polymorphisms in ribonuclease L and prostate cancer risk: a meta-analysis. J Biomed Res. 2010;24(5):365-73. [PubMed ID: 23554651]. https://doi.org/10.1016/S1674-8301(10)60049-8.

  • 8.

    Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, Carpten JD, et al. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates. Cancer Res. 2003;63(20):6795-801. [PubMed ID: 14583476].